GSK250110C30000
- 0.00
- 0.000.00%
GlaxoSmithKline Newsroom
Sector Update: Health Care Stocks Higher in Afternoon Trading
Sector Update: Health Care
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Top Midday Stories: Meta Platforms to Test EBay Listings on Facebook Marketplace; Quantum Computing Stocks Fall After Nvidia CEO's Comments
Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com
Update: Market Chatter: GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion
GSK Nearing $1 Billion Deal to Acquire US Biotech IDRx, FT Reports
Express News | 'GSK Nears $1bn Deal for Biotech Developing Drug for Rare Tumour' - Financial Times
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
The FDA states that GlaxoSmithKline (GSK.US) and Pfizer (PFE.US) RSV vaccines must include warnings about the rare risk of paralysis.
The FDA stated that a vaccine produced by GlaxoSmithKline (GSK.US) and Pfizer (PFE.US) must include a warning about the potential increased risk of a rare neurological side effect.
Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death -- Barrons.com
GSK's Bone Cancer Treatment Receives Breakthrough Designation From US FDA
GSK's Experimental Cancer Drug Wins Receives Support From US Regulator | LSE:GSK, NYSE:GSK
Bernstein Remains a Buy on GlaxoSmithKline (GSK)
Bird Flu Claims First U.S. Life in Louisiana
'LDH Reports First U.S. H5N1-Related Human Death' - Louisiana Department Of Health